Sex: M
Vaccine: COVID19, COVID19
Symptoms: Occipital neuralgia, SARS-CoV-2 test
Clinical narrative: pain at the injection site; anaphylaxis; This is a spontaneous report from a contactable other hcp.   A 27-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported.  The patient's concomitant medications were not reported. The patient experienced pain at the injection site on an unspecified date with outcome of recovered, anaphylaxis on 08Jan2021 with outcome of recovered.  HCP stated he experienced pain at the injection site after the 1st dose that lasted 24 hours. No medication required. IN regards the 2nd dose, 20-30 seconds after the administration he felt lightheaded, little short of breath. 30minutes after he left the facility, he started getting the symptoms fatigue, shortness of breath lightheaded, feeling like passing out on and off for the next 2-3 hours. Recovered on it own. No medication required. He stated he has completely recovered. Also, he mentioned he had a lot of posterior lymph pain in the back of his head, for 2 weeks on and off.Resolved on its own. He developed a sensation like he was going to lose control of his mind, heaviness at the back of his head left side. He went to ER and they provided Valium.HCP stated that 3 weeks after he reacted to his regular allergy shots. He has never reacted to this medication. Reaction with similar manifestation such as Shortness of Breath, and chest tightness. He mentioned he was started on Protonix 1.5 weeks ago. 20-30 seconds after the administration he felt lightheaded, little short of breath. 30 minutes after he left the facility, he started getting the symptoms fatigue, shortness of breath lightheaded, feeling like passing out on and off for the next 2-3 hours. Recovered on it own. No medication required. He stated he has completely recovered. Did the patient require medical intervention?no. Was/Is the patient seen in the Emergency Department?yes. Was/Is the patient hospitalized?No. Was/Is the patient admitted to an Intensive Care Unit?No. provide information on organ involvement: Bilateral wheeze/bronchospasm:Yes. Stridor;No. Upper airway swelling:Yes. Respiratory distress:Yes. Tachypnoea:Yes. Increased use of accessory respiratory muscles:Yes. Recession:No. Cyanosis:No. Grunting:No. Dry cough;Yes. Hoarse voice:No. Difficulty breathing (without wheeze or stridor):Yes. Sensation of throat closure:Yes. Sneezing:Yes. Rhinorrhea:Yes. Tachycardia:Yes. Other:Yes. Details: Hypertension, confusion. Dermatological/Mucosal:No. Nausea:Yes. Did the event require the initiation of new medication or other treatment or procedure?No. Patient's outcome following the potential anaphylactic reaction: Recovered. Was the patient taking any medications prior to the event being reported?Yes. Did the patient receive any recent vaccines for any other conditions prior to the event being reported?no. Did the patient receive any recent vaccines for SARS-CoV2 other than Pfizer-BioNTech COVID-19 Vaccine prior to the event being reported?No. Has the patient received any other vaccines around the time of Pfizer-BioNTech COVID-19 Vaccine vaccination?No.; Sender's Comments: Anaphylactic reaction and Vaccination site pain occurred after receiving the BNT162b2 vaccine.  The events are known adverse reactions attributed to the vaccine. The Company considers a reasonable causality between the vaccine administration and the reported events.